Advertisement
Research Article

Cost Effectiveness of Different Treatment Strategies in the Treatment of Patients with Moderate to Severe Rheumatoid Arthritis in China

  • Bin Wu,

    Affiliation: Clinical Outcomes and Economics Group, Department of Pharmacy, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, People's Republic of China

    X
  • Alisa Wilson,

    Affiliation: Division of Rheumatology, Cedars-Sinai Medical Center, Los Angeles, California, United States of America

    X
  • Fang-fang Wang,

    Affiliation: Department of Rheumatology, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, People's Republic of China

    X
  • Su-li Wang,

    Affiliation: Department of Rheumatology, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, People's Republic of China

    X
  • Daniel J. Wallace,

    Affiliation: Division of Rheumatology, Cedars-Sinai Medical Center, Los Angeles, California, United States of America

    X
  • Michael H. Weisman,

    Affiliation: Division of Rheumatology, Cedars-Sinai Medical Center, Los Angeles, California, United States of America

    X
  • Liang-jing Lu mail

    lu_liangjing@medmail.com.cn

    Affiliation: Department of Rheumatology, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, People's Republic of China

    X
  • Published: October 09, 2012
  • DOI: 10.1371/journal.pone.0047373

Media Coverage of this Article

Found additional news media or blog coverage for the article? Please let us know.